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necessary to select high-affinity antibodies. Therefore,
study of the BCR signaling cascade and factors that
regulate it is critical to understanding B cell development
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The complexity of BCR function may reflect its interac-²Committee on Immunology
tion with multiple signal transduction pathways. For ex-³Department of Pathology
ample, binding of antigens to cell surface Ig results in§Department of Medicine
rapid phosphorylation of tyrosine residues in the immu-University of Chicago
noreceptor tyrosine-based activation motifs (ITAMs) ofChicago, Illinois 60637
Iga and Igb (Gold et al., 1991). Members of the src kinase
family (lyn, fyn, blk, etc.) are associated at low stoichiom-
etry with the unstimulated BCR complex (Lin and Juste-Summary
ment, 1992) and have been implicated in phosphorylat-
ing Iga and Igb as well as numerous other cellularPU.1 and Spi-B have previously been implicated in the
substrates upon BCR stimulation. The tyrosine kinaseregulation of genes encoding B cell receptor (BCR) sig-
syk is thought to be recruited to phosphorylated Iganaling components. Spi-B2/2 B lymphocytes respond
and Igb cytoplasmic tails via its tandem SH2 domainspoorly to BCR stimulation; PU.12/2 mice, however, lack
and has been shown to phosphorylate additional signal-B cells, precluding an analysis of BCR responses. We
ing molecules, including phospholipase C (PLC) (Law etnow show that PU.11/2Spi-B2/2 B cells exhibit more
al., 1996a).extensive defects than Spi-B2/2 B cells, indicating that
In addition to kinases, several phosphatases (SHP-1,both PU.1 and Spi-B are required for normal BCR sig-
SHIP-1, and CD45) and adaptor proteins (BLNK/SLP-naling. Strikingly, BCR cross-linking results in sub-
65, Grb2, Shc, and Nck) also regulate BCR signal trans-stantially reduced protein tyrosine phosphorylation in
duction (Justement et al., 1991; Park and Rhee, 1992;mutant B cells. Further analysis shows that Iga is
Lankester et al., 1994; Smit et al., 1994; Campbell andphosphorylated and syk is recruited and becomes
Klinman, 1995; Law et al., 1996b; Pao et al., 1997; Bol-phosphorylated but that BLNK and PLCg phosphoryla-
land et al., 1998; Fu et al., 1998; Wienands et al., 1998).tion are defective in mutant cells. Our data support
The protein BLNK/SLP-65, which shares homology with
the existence of a novel component coupling syk to
the T cell adaptor protein SLP-76, appears to serve as
downstream targets.
a scaffolding protein mediating interaction of syk with
PLCg, Vav, Grb2, and Nck (Fu et al., 1998; Wienands
Introduction et al., 1998). BCR stimulation induces protein tyrosine
phosphorylation, the mobilization of Ca21 stores, and
The B cell receptor (BCR) complex consists of mem- protein kinase C and MAP kinase activation (reviewed
brane-bound immunoglobulin (Ig) noncovalently associ- in Tamir and Cambier, 1998), resulting in B cell functional
ated with two signal-transducing proteins, Iga (CD79a) responses including proliferation, isotype switching,
and Igb (CD79b) (reviewed in Cambier et al., 1994). BCR and/or antibody secretion.
signaling is critically important at many stages of B cell Binding sites for the Ets family of transcription factors
development. For example, during the early stages of have been identified in several genes encoding BCR
B lymphopoiesis in the bone marrow, signals transduced signaling proteins including Ig heavy and light chains
through a pre-BCR complex are necessary for positive (Pongubala et al., 1992; Eisenbeis et al., 1993; Nelsen
selection of cells expressing a functional Ig heavy chain et al., 1993), Ig J chain (Shin and Koshland, 1993), Iga
allele, for allelic exclusion of further heavy chain re- (Feldhaus et al., 1992; Hagman and Grosschedl, 1992),
arrangements, and for the expansion of precursor popu- Igb (Omori and Wall, 1993), and the tyrosine kinases Btk
lations (Kitamura et al., 1991, 1992; Gong and Nussen- (Sideras et al., 1994; Muller et al., 1996) and blk (Lin
zweig, 1996). Immature B cells in the bone marrow and et al., 1995). Although seven Ets family members are
peripheral tissues whose BCR molecules are reactive expressed in B cells (Ets-1, Ets-2, PU.1, Spi-B, Fli-1,
with self-antigen undergo receptor editing, deletion, or Elf-1, and GABPa) (Bassuk and Leiden, 1997), two of
inactivation (anergy). Mature B cells in the periphery these proteins, PU.1 and Spi-B, are particularly abun-
require the presence of surface BCRs and presumably dant. PU.1 and Spi-B are closely homologous to each
low levels of BCR signaling for survival (Lam et al., 1997). other but less well conserved with other Ets proteins
Moreover, recognition and internalization of foreign anti- (Ray et al., 1992). Spi-B is expressed exclusively in
lymphoid cells: high levels are detected in B cells andgens by B cells occurs via their binding to the BCR
low levels in T cell progenitors (Ray et al., 1992; Chencomplex. Finally, during the process of affinity matura-
et al., 1995a; Su et al., 1996). In contrast, expression oftion, interaction of antigens with the BCR complex is
PU.1 is more widespread in hematopoietic cells, includ-
ing both myeloid (granulocyte, monocyte, and osteoclast)‖ To whom correspondence should be addressed (e-mail: csimon@
and lymphoid (B and immature T lymphocytes) lineagesmedicine.bsd.uchicago.edu).
and also hematopoietic progenitor cells (Klemsz et al.,# Present address: Department of Pathology, Johns Hopkins Univer-
sity Medical Center, Baltimore, Maryland 21205. 1990; Ray et al., 1992; Voso et al., 1994; Chen et al.,
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1995a; Su et al., 1996; Tondravi et al., 1997). In vitro but that downstream targets are not properly phosphor-
ylated. These results suggest the existence of a pre-assays have shown that Spi-B and PU.1 bind to similar
or identical DNA sequences and transactivate the same viously unknown component of the BCR signaling cas-
cade coupling syk to downstream effectors whosereporter gene constructs in transient transfection as-
says (Ray et al., 1992; Chen et al., 1995b; Muller et expression is regulated by PU.1 and Spi-B. In keeping
with the BCR signaling defect, PU.11/2Spi-B2/2 mice ex-al., 1996; Su et al., 1996). Because PU.1 and Spi-B are
expressed in overlapping patterns in mice and bind simi- hibit increased rates of B cell apoptosis and reduced
numbers of peripheral B cells. Surprisingly, despite thelar DNA sequences, it is likely that they regulate overlap-
ping sets of target genes and may be in part functionally severe BCR signaling defect in mutant animals, B cell
lymphopoiesis is apparently normal, raising the possibil-redundant.
To determine the in vivo function of PU.1 and Spi-B, ity that signal transduction through the pre-BCR and
BCR complexes is not identical.we have disrupted the genes encoding these proteins in
ªknockoutº mice. Deletion of PU.1 results in a complete
block to lymphoid (B and T cells) and myeloid (macro- Results
phages and neutrophils) development during fetal he-
matopoiesis and in late-stage embryonic lethality (Scott Generation of PU.11/2Spi-B1/2 and
et al., 1994). More recent data indicate that PU.1 is re- PU.11/2Spi-B2/2 Mice
quired for the survival and differentiation of a previously To investigate the possibility of functional redundancy
unknown lymphoid-myeloid progenitor (Scott et al., between PU.1 and Spi-B and the role, if any, of PU.1 in B
1997). In contrast, independently generated PU.12/2 cells, we crossed PU.11/2 and Spi-B2/2 mice to generate
mice survive embryogenesis and birth but subsequently animals with the genotypes PU.11/2Spi-B1/2, PU.11/2
die from pathogenic infection (McKercher et al., 1996). Spi-B2/2, and PU.12/2Spi-B2/2. Although PU.12/2 mice fail
Neonatal mice with this PU.1 allele develop some B2201 to generate any myeloid or lymphoid cells and die in
cells in bone marrow and spleen, but these cells fail to the latter half of embryogenesis, it was important to
differentiate properly or to rearrange the Ig heavy chain. determine whether PU.12/2Spi-B2/2 mice exhibited a
Since both PU.1 alleles result in a lack of mature B cells, more severe defect indicating a possible role for Spi-B
it has not previously been possible to define a role, if in hematopoietic progenitors. However, PU.12/2Spi-B2/2
any, for PU.1 in B cells. and PU.12/2 embryos showed identical flow cytometry
Surprisingly, mutation of the Spi-B locus results in profiles for all hematopoietic lineages at every time point
viable mice that do not display detectable develop- examined (data not shown). Moreover, PU.12/2 and
mental defects in any hematopoietic lineages (Su et PU.12/2Spi-B2/- embryos died at the same stage of em-
al., 1997). However, Spi-B2/2 B cells exhibit a functional bryonic development. Therefore, Spi-B does not appear
defect in their ability to respond to antigenic stimulation to be necessary for the development of hematopoietic
through the BCR. Spi-B2/2 mice produce reduced amounts progenitors.
of antibody in response to immunization with a T-depen- In contrast, mice with the genotypes PU.11/2Spi-B1/2
dent antigen, dinitrophenyl-keyhole limpet hemocyanin and PU.11/2Spi-B2/2 were viable and fertile, allowing us
(DNP-KLH). Examination of spleens of immunized ani- to examine adult hematopoiesis and blood cell function.
mals shows that Spi-B2/2 mice develop small, ill-defined Both PU.1 and Spi-B have been shown to transcription-
germinal centers compared to wild-type mice. More- ally activate the PU.1 gene (Chen et al., 1995b), indicat-
over, these germinal centers deteriorate early due to ing the possibility that B cells from mutant animals might
increased B cell apoptosis. In vitro, Spi-B2/2 B cells pro- express lower levels of PU.1 protein than expected
liferate poorly in response to BCR stimulation, whereas based on their genotype. PU.1 protein levels in mutant
proliferation in response to lipopolysaccharide (LPS) is B cells were examined via Western blot analysis using
normal. Together, these results suggest that Spi-B2/2 B extracts of B cells purified from the spleens of adult
cells are defective in one or more components of the mice. PU.1 expression levels correlated with the PU.1
signaling pathways activated by BCR stimulation. More- genotype (i.e., PU.11/2 cells express approximately half
over, these data indicate that Spi-B performs some as much PU.1 protein as do PU.11/1 cells) irrespective
unique function(s) in B cells not compensated by the of the Spi-B genotype (data not shown).
closely related PU.1 protein.
Collectively, these studies indicate that both Spi-B Examination of Hematopoietic Lineages
and PU.1 are important in hematopoiesis but play dis- in Mutant Mice
tinct roles. As they bind identical DNA elements, how- We examined the presence of various hematopoietic
ever, PU.1 and Spi-B may also share some overlapping lineages in PU.11/2Spi-B1/2 and PU.11/2Spi-B2/2 mice
functions masked in the respective ªknockoutº animals compared to wild-type and Spi-B2/2 mice using flow
due to functional redundancy. To identify possible roles cytometric analysis of characteristic cell surface anti-
of PU.1 in B lymphocytes and assess redundancy with gens. Flow cytometric profiles for myeloid lineages were
Spi-B, we crossed PU.11/2 mice to Spi-B2/2 mice to identical in all genotypes (data not shown). Since both
generate animals with the genotypes PU.11/2Spi-B1/2, PU.1 and Spi-B are expressed in T cell progenitors and
PU.11/2Spi-B2/2, and PU.12/2Spi-B2/2. We show that both then downregulated as the cells mature, T cell develop-
PU.1 and Spi-B are required for normal BCR signal trans- ment might be compromised in mutant animals. How-
duction in that mutant B cells exhibit greatly reduced ever, CD4/CD8 profiles in thymus and spleen and
tyrosine phosphorylation and Ca21 mobilization upon TCRab/CD3 profiles in the spleen of adult animals were
BCR cross-linking. Our data indicate that syk is recruited comparable (data not shown), suggesting that the devel-
opment and survival of T cells in adult mice is normal.to Iga/Igb and phosphorylated upon BCR cross-linking
Normal BCR Signaling Requires PU.1 and Spi-B
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Figure 1. A B Cell Deficiency Is Present in PU.11/2Spi-B2/2 Mice
(A and B) PU.11/2Spi-B2/2 mice exhibit fewer immature and mature B lymphocytes in the spleen and lymph nodes as compared to wild-type
littermates (absolute numbers of B cells in spleen: wild-type 31.1 3 106 6 1.7 3 106, PU.11/2Spi-B2/2 15.9 3 106 6 3.3 3 106 [p , 0.02], and
lymph node: wild-type 2.8 3 106 6 0.5 3 106, PU.11/2Spi-B2/2 1.0 3 106 6 0.1 3 106 [p , 0.07]). Flow cytometry performed on the indicated
tissue specimens assayed B220/IgM and IgD/IgM staining. Differences in IgD staining between genotypes are largely due to differences in
fluorescence intensity between the IgDa and IgDb antibodies used. Modest reductions in the numbers of IgM1IgD2 and IgM1IgD1 B cells were
detected in 30% of the PU.11/2Spi-B1/2 animals. (C) PU.11/2Spi-B2/2 mice produce normal numbers of pro-B and pre-B cells. FACs analysis
of total bone marrow cells showed that the number of B2201S71 (pro-B) cells in PU.11/2Spi-B2/2 mice was normal, whereas the number of
B2201S72 (comprising to the pre-B, immature B, and mature recirculating B) cells was reduced. To further define the developmental stage
at which differences were noted, B220/BP-1 staining was performed. PU.11/2Spi-B2/2 mice showed normal numbers of B2201BP-11 (pro- and
pre-B) cells but reduced numbers of B2201BP-12 (immature and mature recirculating B) cells. Differences in the total number of B2201 cells
between panels is due to the fact that different mice were used in the two experiments. To confirm stage at which B cell numbers were
reduced, three-color FACs analyses were performed. The B2201S72 population was gated and is shown in (D). The majority of the B2201S72 cells
in PU.11/2Spi-B2/2 bone marrow are B220intIgM2 and B220intHSAhi, signifying the presence of pre-B cells at the expense of more differentiated cell
types. B220hiIgM1HSAlo immature and mature B cells represent a minor population in the PU.11/2Spi-B2/2 bone marrow. These results are
consistent with the presence of normal numbers of B2201BP-11 pro- and pre-B cells in mutant bone marrow, shown in (D). (E) Mutant B cells
express increased levels of surface IgM. Purified splenic B cells from PU.11/1Spi-B1/1, PU.11/2Spi-B1/2, PU.11/1Spi-B2/2, and PU.11/2Spi-B2/2
mice were stained with IgM-FITC and analyzed by flow cytometry. The peak fluorescence intensity for each sample (indicated by the numbers
in the upper right corner) shows that B cells from PU.11/1Spi-B2/2 and PU.11/2Spi-B2/2 mice on average express higher levels of surface IgM
than B cells from PU.11/1Spi-B1/1 or PU.11/2Spi-B1/2 mice.
PU.1 and Spi-B are both abundantly expressed in B was higher in splenocytes of mutant animals than wild-
type littermates. Figure 1E shows that B cells purifiedcells and their progenitors. Flow cytometric analysis (n 5
6 for each genotype) showed that PU.11/2Spi-B2/2 mice from Spi-B2/2 and PU.11/2Spi-B2/2 spleens display 2- to
4-fold higher levels of surface IgM staining. Differencesexhibited a reduced number of B2201IgM1 and Ig-
M1IgD1 B cells in the spleen (50% reduction) and lymph in IgD staining noted in Figures 1A and 1B are due to
differences in the fluorescent intensity of the antibodiesnodes (60% to 80% reduction) (Figures 1A and 1B),
whereas Spi-B2/2 and PU.11/2Spi-B1/2 mice were nor- for IgDa and IgDb (our mice are hybrids of C57BL/6
and 129Sv and express either IgDa, IgDb, or both). How-mal. Furthermore, the reduced percentage of B cells
in PU.11/2Spi-B2/2 mice was correlated with a reduced ever, we cannot rule out that the increased levels of
IgD staining noted in Spi-B2/2, PU.11/2Spi-B1/-, andabsolute number of B cells. We noted that surface IgM
Immunity
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PU.11/2Spi-B2/2 mice may be in part due to increased
surface IgD levels similar to the results obtained with
surface IgM. Mutant B cells also express higher levels
of surface CD19 and CD21 than do wild-type cells (data
not shown).
To determine the stage of B cell development with a
reduction in cell numbers, we examined PU.11/2Spi-B2/2
bone marrow. We detected 50% fewer IgM1IgD2 and
IgM1 IgD1 B cells in the bone marrow of PU.11/2Spi-B2/2
mice (data not shown). Subsequent analysis showed that
the percentages of B2201S72 and B2201BP-12 B cells
in bone marrow were reduced whereas the percentage
of B2201S71 and B2201BP-11 cells was normal (Figure
1C). To further define the developmental stage at which
B cell numbers were reduced, three-color flow cytome-
try of bone marrow suspensions was performed (Figure
1D), which indicated that the B220hi/intS72IgM1 (im-
mature and mature B cells) population was reduced
whereas the B220intS72IgM2 population (pro- and pre-B
cell) was normal (Hardy et al., 1991). Confirming these
results, we noted that the B220hiS72HSAlo population
was reduced whereas the B220intS72HSAhi population
was normal (Figure 1D). Therefore, adult PU.11/2Spi-B2/2
mice have normal numbers of pro- and pre-B cells in
the bone marrow but show a deficiency in the numbers
of immature and mature B cells in the bone marrow and
peripheral tissues. Interestingly, examination of B cell
precursors in the fetal liver at embryonic day 16.5
showed normal numbers of B2201S71 cells but reduced
numbers of B2201S72 cells, indicating that a B cell defi-
ciency is present in fetal as well as adult hematopoiesis
(data not shown).
The Ig kappa (k) and lambda (l) light chain genes are
putative targets of Ets transcription factors (Pongubala
et al., 1992; Eisenbeis et al., 1993), and mice that lack
Figure 2. IgM1IgD2 and IgM1IgD1 B Lymphocytes in PU.11/2
k light chain expression exhibit a 50% reduction in the Spi-B2/2 Spleen Exhibit High Levels of Apoptosis
numbers of peripheral B cells (Chen et al., 1993) similar Spleen cells were stained with IgM (cychrome) and IgD (PE), incu-
to the B cell deficiency noted in PU.11/2Spi-B2/2 mice. bated with Annexin V (FITC), and analyzed by flow cytometry. Ig-
Flow cytometric analysis of B cell populations in the M1IgD2 and IgM1IgD1 populations were gated. Increased rates of
apoptosis were observed for both immature and mature B cells inbone marrow and periphery detected normal levels of
spleens obtained from PU.11/2Spi-B2/2 animals.cell surface k and l on mutant B cells, demonstrating
that both of these gene products are expressed normally
(data not shown). Moreover, expression of the k light
from wild-type animals (data not shown). Therefore, in-chain gene in sorted pre-B (B2201 S72IgM2) cells iso-
creased apoptosis of immature and mature B cells inlated from bone marrow of Spi-B2/2 and PU.11/2Spi-B2/2
PU.11/2Spi-B2/- mice probably accounts for the reducedmice was normal based on RNase protection assays
number of B cells in the bone marrow and peripheralof k constant region transcription (data not shown).
lymphoid organs.Therefore, we have excluded reduced expression of Ig
light chain genes as a cause of B cell deficiency in
Mutant Animals Exhibit B Cell Functional DefectsPU.11/2Spi-B2/2 mice.
We have previously shown that Spi-B2/2 mice, upon im-Flow cytometric analysis of bone marrow populations
munization with a T-dependent antigen DNP-KLH, formin PU.11/2Spi-B2/2 mice showed normal numbers of
small, poorly organized germinal centers that deterio-pro-B and pre-B cells indicating that there is no develop-
rate early (Su et al., 1997). The mutant germinal centersmental block to B lymphopoiesis. However, we detected
are characterized by increased B cell apoptosis, likelyreduced numbers of immature and mature B cells in
accounting for their premature disappearance. Wethese mice, implying that these cells may be lost at
asked whether PU.11/2Spi-B1/2 and PU.11/2Spi-B2/2increased rates in PU.11/2Spi-B2/2 animals. To test this
mice showed similar or more severe defects in germinalhypothesis, we examined the rate of apoptosis of Ig-
center formation. Peanut agglutinin (PNA) staining ofM1IgD2 immature and IgM1IgD1 mature B cells in
splenic sections on days 10 and 28 post antigenic chal-spleen (Figure 2) using Annexin V staining. Three to
lenge with DNP-KLH showed clearly defined germinalfour times as many Annexin Vhi apoptotic immature and
centers in wild-type mice (Figure 3). Both Spi-B2/2 andmature B cells were detected in PU.11/2Spi-B2/2 mice
PU.11/2Spi-B1/2 mice developed smaller germinal cen-than in mice with other genotypes (n 5 3). Furthermore,
ters at day 10 that had disappeared by day 28. In markedfour times as many B2201 TUNEL1 lymphocytes were
present in PU.11/2Spi-B2/2 spleens as those harvested contrast, PU.11/2Spi-B2/2 mice showed no evidence of
Normal BCR Signaling Requires PU.1 and Spi-B
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Figure 3. PU.11/2Spi-B2/2 Mice Fail to Form
Germinal Centers
Spleen sections were obtained from
PU.11/1Spi-B1/1 (A and B), PU.11/1Spi-B2/2
(C and D), PU.11/2Spi-B1/2 (E and F), and
PU.11/2Spi-B2/2 mice (G and H) at day 10 (A,
C, E, and G) and day 28 (B, D, F, and H) post
DNP-KLH immunization and stained with
peanut agglutinin (PNA). PNA1 germinal cen-
ter B cells appear as dark brown areas as
indicated by the white arrows.
PNA1 germinal centers at either day 10 or day 28 post Mutant B Cells Exhibit Defective Tyrosine
Phosphorylation and Ca21 Mobilizationimmunization.
We have shown that early deterioration of germinal upon BCR Cross-Linking
Reduced in vitro proliferation potential to IgM cross-centers in Spi-B2/2 mice is correlated with an increased
number of B2201/TUNEL1 cells in immunized mice than linking indicates that Spi-B2/2 and PU.11/2Spi-B2/2 B
cells exhibit abnormal responses to BCR-mediatedin wild-type animals (Su et al., 1997). To determine
whether the lack of germinal centers in PU.11/2Spi-B2/2
mice was also consistent with increased rates of apopto-
sis of splenic B cells, we performed B220/TUNEL stain-
ing. On day 21 post DNP-KLH immunization, PU.11/2
Spi-B2/- spleens contained 3±4 times as many apoptotic
cells as wild-type spleens. These apoptotic cells were
largely B cells as assessed by costaining with an anti-
B220 antibody. Therefore, like Spi-B2/2 mice, PU.11/2
Spi-B2/2 mice exhibit increased rates of B cell apoptosis
in the spleen upon immunization with a T-dependent
antigen. This increased susceptibility of B cells to apo-
ptosis may explain the failure of PU.11/2Spi-B2/2 mice to
form germinal centers. We conclude that Spi-B2/2, PU.11/2
Spi-B1/2, and PU.11/2Spi-B2/2 mice exhibit defects in
germinal center formation and maintenance accompa-
nied by increased rates of apoptosis.
To further examine the functional response of mutant
B cells, we purified B cells from the spleens of wild-type
and mutant mice and studied their in vitro proliferative
responses to various mitogenic stimuli. Like Spi-B2/2 B
cells, PU.11/2Spi-B2/2 B cells showed a defect in their
proliferative response to an anti-IgM antibody (Figures
4A and 4B), but the defect was significantly more severe
(10- to 20-fold reduction [p , 2 3 1026] versus a 3-fold
reduction for Spi-B2/2 or PU.11/2Spi-B1/2 (p , 2 3 1023).
Mutant B cells proliferated normally in response to an
anti-CD40 antibody and the cytokine IL-4; however, these
costimulatory signals were not sufficient to rescue poor
proliferation in response to BCR ligation (Figure 4B).
Proliferation in response to the polyclonal B cell mi-
togen LPS is nearly normal for Spi-B2/2 and PU.11/2
Spi-B1/2 B cells, whereas PU.11/2Spi-B2/2 B cells show a
2- to 3-fold reduction in their response to this compound
(p , 0.003) (Figure 4A). Importantly, B cells of all geno-
types were capable of normal proliferation in response
to phorbol 12-myrisate 13-acetate (PMA, an activator of Figure 4. B Cell Proliferative Responses Assayed In Vitro
protein kinase C [PKC]) and ionomycin (a Ca21 iono- Splenic B cells were isolated from PU.11/1Spi-B1/1 (white bars),
phore) (Figure 4A). PMA and ionomycin mimic the signal- PU.11/2Spi-B1/2 (gray bars), PU.11/1Spi-B2/2 (striped bars), and
ing pathways downstream of the BCR in part by activat- PU.11/2Spi-B2/2 (black bars) animals and stimulated with the indi-
cated mitogens. Data are represented as the mean and standarding the same pathways as phospholipase C (PLC). Since
error of at least four independent experiments. (A) B cells weremutant B cells respond normally when stimulated by
stimulated with 50 mg/ml F(ab')2 fragment of anti-IgM antibody, 50PMA and ionomycin but fail to respond properly to BCR
mg/ml LPS, or 10 ng/ml PMA and 0.5 mg/ml ionomycin. (B) B cells
stimulation, we conclude that the defect in these cells were stimulated with suboptimal amounts (3 mg/ml) of F(ab')2 frag-
lies in a membrane-proximal step between the BCR and ment of anti-IgM antibody alone or in combination with 10 mg/ml
anti-CD40 antibodies or 10 ng/ml recombinant IL-4.PLC (see Figure 6).
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Figure 5. Mutant B Cells Exhibit Reduced BCR Signaling
Protein extracts of splenic B cells purified from mice with the indicated genotypes were resolved by SDS-PAGE, transferred to nitrocellulose
membranes, and probed with the anti-phosphotyrosine mAb 4G10. Prior to lysis, B cells were either mock stimulated with media or stimulated
with 50 mg/ml F(ab')2 fragment of anti-IgM antibody for the indicated times (A) or 2.5 mM Na3VO4/0.3% H2O2 for 1 min (B). (C) Purified splenic
B cells were incubated with the Ca21-sensitive dyes Fluo-3 and Fura-Red. Basal fluorescence ratios of cells at 378C were measured for 30 s.
Anti-IgM antibody was added to 50 mg/ml, and fluorescence changes were measured for an additional 4 min. Results are represented in
arbitrary units as changes in fluorescence ratio over time. (D) Lysates from purified splenic B cells were immunoprecipitated with the indicated
antibodies. Immunoprecipitates were Western blotted using the anti-phosphotyrosine antibody 4G10. Blots were then stripped and reprobed
with the indicated antibodies. The decrease in syk phosphorylation exhibited by PU.11/2Spi-B2/2 B cells compared to wild-type cells was not
reproducible, whereas decreases in the phosphorylation of BLNK and PLCg2 were.
stimuli. To more directly test this, we measured the lev- these results also indicate that the decreased tyrosine
phosphorylation levels evident in mutant cell lysatesels of tyrosine phosphorylation induced by IgM cross-
linking. PU.11/2Spi-B1/2, Spi-B2/2, and PU.11/2Spi-B1/2 cannot be explained exclusively by the overactivity or
overabundance of a protein tyrosine phosphatase suchB cells exhibited reduced levels of tyrosine phosphoryla-
tion compared to wild-type cells, even after 10 min of as SHP-1.
To further analyze BCR-mediated signaling defects instimulation (Figure 5A). On the other hand, neither
PU.11/2 nor Spi-B1/2 B cells showed a significant tyro- mutant mice, we looked at the ability of mutant B cells
to mobilize Ca21 in response to IgM cross-linking usingsine phosphorylation defect (data not shown). To further
characterize the signaling deficiency in mutant B cells, the Ca21-sensitive dyes Fluo-3 and Fura-Red. Whereas
wild-type B cells display a robust response to BCR stim-we examined the levels of tyrosine phosphorylation in-
duced by pervanadate/H202 treatment (which inhibits ulation, mutant B cells exhibit varying degrees of impair-
ment of Ca21 mobilization with PU.11/2Spi-B2/2 B cellscellular phosphatases). Induction of efficient tyrosine
phosphorylation by this compound requires the expres- showing the greatest defects (Figure 5C).
Both the reduction in tyrosine phosphorylation andsion of a functional BCR complex on the cell surface
(Wienands et al., 1996), suggesting the need for a pre- the normal proliferative response to PMA plus ionomycin
suggest that mutant B cells are defective in a mem-formed BCR signal transducing complex. Spi-B2/2,
PU.11/2Spi-B1/2, and PU.11/2Spi-B2/2 B cells exhibited brane-proximal step of the BCR signaling pathway. We
therefore tested the expression levels of known mem-reduced levels of tyrosine phosphorylation in response
to pervanadate/H202 treatment compared to wild-type brane-proximal protein kinases involved in BCR signal
transduction (lyn, fyn, blk, syk, and Btk). Equivalent lev-cells (Figure 5B), confirming the lack of intact BCR-
mediated signal transduction in mutant B cells. Moreover, els of these kinases were expressed in all genotypes
Normal BCR Signaling Requires PU.1 and Spi-B
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(data not shown). Furthermore, in vitro kinase assays mutant B cells, indicating that it was possible to circum-
vent the signaling defect present in these cells. We con-using enolase as an exogenous substrate demonstrated
clude that one or more membrane-proximal signalingthat the basal kinase activity of syk, lyn, and fyn was
events are defective in mutant B cells but that down-similar in wild-type and mutant B lymphocytes (data not
stream signal transduction pathways are intact and canshown).
be activated. In support of this theory, we show thatAlthough all of the membrane-proximal kinases ap-
tyrosine phosphorylation initiated by IgM cross-linkingpeared to be expressed at normal levels in wild-type
is substantially reduced in Spi-B2/2 and PU.11/2Spi-B1/2and mutant B cells, it was possible that these kinases
B cells and nearly absent in PU.11/2Spi-B2/2 cells. Thewere not localized properly to their targets. Recently,
genes for the immunoglobulin heavy and light chainsan important B cell adaptor protein, BLNK/SLP-65, has
contain Ets binding sites in their regulatory regions (Pon-been described that appears to mediate the association
gubala et al., 1992; Eisenbeis et al., 1993; Nelsen et al.,of the protein kinase syk with several of its putative
1993; Shin and Koshland, 1993). A trivial explanation fortargets (Fu et al., 1998; Wienands et al., 1998). Western
the reduced BCR signaling observed in mutant B cellsblot analysis detected equivalent levels of BLNK in all
is that they express reduced amounts of surface IgM.genotypes (data not shown). We have also shown that
However, we have shown that both Spi-B2/2 and PU.11/2Vav, Iga, and Igb are present at normal levels in mutant
Spi-B2/2 B cells display increased amounts of surfaceB lymphocytes (data not shown).
IgM in flow cytometry analyses. Expression of high lev-To further explore the nature of the signaling defect
els of surface IgM may reflect a compensation for thein mutant lymphocytes, we immunoprecipitated Iga and
reduced capacity of the BCR to signal efficiently in mu-Igb from resting and BCR-stimulated B cells and as-
tant B cells.sessed their tyrosine phosphorylation. Iga (Figure 5D)
Lack of tyrosine phosphorylation in lysates of IgMand Igb (data not shown) are phosphorylated to a similar
cross-linked cells could be caused by the overexpres-extent in wild-type, Spi-B2/2, and PU.11/2Spi-B2/2 B cells
sion or overactivity of a negative regulatory phospha-upon receptor ligation. Moreover, syk was coimmuno-
tase (for instance SHP-1). However, both Spi-B2/2 andprecipitated with Iga/Igb and phosphorylated to similar
PU.11/2Spi-B2/2 B cells show diminished levels of tyro-extents in wild-type and mutant cells (Figure 5D). There-
sine phosphorylation induced by the phosphatase inhib-fore, the first steps of the BCR signaling cascade appear
itor pervanadate/H2O2 when compared to wild-type Bnormal in mutant B cells. We next determined if proteins
cells. Therefore, decreased phosphorylation in mutantdownstream in the BCR signaling cascade, BLNK and
cells cannot be explained by excess phosphatase activ-PLCg, were phosphorylated in mutant B cells. Immuno-
ity and implies that either kinase activity is deficient or,precipitation of these proteins followed by Western blot-
alternatively, that kinase substrates are not localizedting with anti-phosphotyrosine antibodies showed that
properly.tyrosine phosphorylation of both proteins is decreased
Western analysis using extracts of purified B cellsin mutant cells (Figure 5D). Therefore, it appears that
indicates that wild-type and mutant cells express equiv-syk is recruited to Iga/Igb in mutant B cells and becomes
alent amounts of lyn, fyn, blk, syk, and Btk. Moreover,phosphorylated but fails to couple to downstream tar-
mutant B cells also express normal levels of an importantgets. We conclude that mutant B cells are deficient in
membrane-proximal adaptor protein, BLNK/SLP-65. Wean unknown component of the BCR signaling cascade
show that Iga/Igb is phosphorylated in mutant cells,that is required for the interaction of syk with down-
suggesting that src family kinases are activated uponstream proteins such as BLNK and PLCg whose expres-
receptor cross-linking. Moreover, normal amounts ofsion is dependent on PU.1 and Spi-B.
syk are recruited to Iga/Igb and phosphorylated. Binding
of syk to phosphorylated ITAM motifs (Rowley et al.,
1995; Shiue et al., 1995) and its phosphorylation (Rowley
Discussion
et al., 1995; Couture et al., 1997) have been shown to
activate the enzyme, and it is, therefore, likely that syk
Reduced Levels of Substrate Tyrosine is activated in our mutant B cells. Interestingly, however,
Phosphorylation upon IgM Cross-Linking putative syk target genes BLNK and PLCg are poorly
in Mutant B Cells phosphorylated, suggesting that these substrates may
This investigation establishes a novel, unexpected func- not be properly recruited to syk. Therefore, we propose
tion for the Ets transcription factor PU.1 in BCR signal- that Spi-B2/2, PU.11/2Spi-B1/2, and PU.11/2Spi-B2/2 B
ing. In the absence of Spi-B, it is apparent that PU.1, cells express inadequate levels of an unidentified com-
in a gene dosage-dependent fashion, regulates the ex- ponent(s) of BCR signaling pathways crucial for recruit-
pression of one or more genes critical for proper BCR ing BLNK, PLCg, and other substrates to syk and for
signal transduction. B cells from Spi-B2/2, PU.11/2Spi-B1/2, normal BCR-mediated events (designated X in Figure 6).
and PU.11/2Spi-B2/2 mice exhibit a defective germinal
center reaction upon immunization with a T-dependent Functional Defects and Increased Rates
antigen (DNP-KLH) and proliferate poorly in vitro in re- of Apoptosis in Mutant B Cells
sponse to IgM cross-linking. Since both of these events Although all blood cell lineages are present in PU.11/2
require signaling through the BCR, we hypothesized that Spi-B2/2 mice, these animals are characterized by a re-
BCR-mediated signal transduction might be defective in duced number of immature and mature B cells in the
mutant B cells. Importantly, PMA and ionomycin (which bone marrow and peripheral lymphoid organs. In con-
bypass the BCR and activate downstream signaling trast, normal numbers of pro- and pre-B cells are ob-
served in the bone marrow. Immature and mature Bpathways) were able to induce normal proliferation in
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in the bone marrow requires signal transduction through
a pre-BCR complex consisting of the Ig heavy chain in
association with surrogate light chains and the Iga and
Igb molecules. The pre-BCR appears to signal through
at least some of the same protein components as the
BCR (Cheng et al., 1995; Turner et al., 1995; Gong and
Nussenzweig, 1996). Other signaling components of the
BCR pathway are presumed to play a role in pre-BCR
signaling. However, our data support the idea that the
signaling components of the pre-BCR are not identical
to those of the BCR.
In summary, we have shown that both PU.1 and Spi-BFigure 6. Model of BCR-Mediated Signal Transduction
are critical for normal BCR signal transduction. WeakA simplified model of some of the known components involved in
BCR signaling is associated with poor B cell function,the membrane-proximal steps of BCR signaling. Membrane bound
increased apoptosis, and reduced numbers of immatureIgM in association with Iga and Igb constitutes the BCR complex.
Src family kinases phosphorylate the ITAM motifs of Iga and Igb. and mature B cells. B cells from mutant mice fail to
Syk then binds to the phospho-ITAMs via its SH2 domains and initiate proper tyrosine phosphorylation upon BCR liga-
interacts with downstream targets including BLNK and PLCg. We tion although normal levels of all known proximal BCR
theorize that Spi-B2/2 and PU.11/2Spi-B2/2 B cells lack expression
signaling proteins are detected. Although syk is re-of some critical component X, which is required for coupling down-
cruited to the BCR complex and becomes phosphory-stream proteins to syk.
lated, its putative targets display reduced phosphoryla-
tion. We propose that PU.1 and Spi-B together regulate
an unknown component(s) of the BCR signaling cascadecell populations in the spleens of PU.11/2Spi-B2/2 mice
required for coupling syk to its substrates. As such,exhibit increased binding of Annexin V, indicating that
PU.11/2Spi-B2/2 B lymphocytes represent an ideal modelthey are undergoing increased rates of apoptosis. In-
system to identify additional proximal molecules essen-creased apoptosis within these populations likely ac-
tial for these events.counts for the reduced number of peripheral B cells that
characterizes PU.11/2Spi-B2/2 mice. Poor BCR-induced
tyrosine phosphorylation is observed in antigen-desen- Experimental Procedures
sitized and anergic B cells (Cooke et al., 1994; Vilen et al.,
Cell Counts and Flow Cytometry Analysis1997), but unlike PU.11/2Spi-B2/2 B cells, they express
Single cell suspensions were prepared from the indicated tissuesreduced levels of surface IgM. Normal peripheral B cells
and lysed with ammonium chloride buffer. For flow cytometry analy-
appear to require a surface Ig and presumably a low sis, each sample was stained with FITC-labeled monoclonal anti-
level of BCR signaling to survive (Lam et al., 1997), and body (mAb) (IgM or CD43; Pharmingen), PE-labeled mAb (B220,
anergic B cells, which exhibit reduced BCR signaling, IgDa, or IgDb; Pharmingen), and/or biotin-conjugated mAb (IgM, S7,
HSA, or BP-1; Pharmingen) followed by cychrome-labeled streptavi-undergo increased rates of apoptosis. PU.11/2Spi-B2/2
din (Pharmingen) as previously reported (Su et al., 1997). For analysisB cells exhibit a severe defect in substrate tyrosine
of apoptotic B cells in bone marrow and spleen, a single cell suspen-phosphorylation upon BCR stimulation despite express-
sion was stained first with PE-labeled IgDa, PE-labeled IgDb, and
ing increased levels of surface IgM. A reasonable expla- biotin-conjugated IgM followed by cychrome-labeled streptavidin.
nation for the increased rates of apoptosis among Cells were washed in 1X binding buffer supplied in the Apoptosis
PU.11/2Spi-B2/2 immature and mature B cells is that they Detection Kit (R & D Systems) and then incubated with FITC-labeled
Annexin V. Labeled cells were analyzed by the LYSIS II program orreceive insufficient BCR-dependent signals to permit
the CellQuest program of a FACScan instrument (Becton Dickinson)survival.
and quantitated by CellQuest or WINmidi software. Ten thousandIt could be hypothesized that the lack of a strong
events were collected per dot plot.
positive signal from the BCR might interfere with nega-
tive selection and result in the production of increased
Antigenic Challenges and Immunohistochemistry
numbers of autoreactive B cells in mutant mice. At pres- Mice were immunized with DNP-KLH, and immunohistochemistry
ent, we have no evidence for the production of autoreac- was performed to determine the number of B2201/TUNEL1 cells in
tive cells in Spi-B2/2 nor in PU.11/2Spi-B2/2 mice. In con- sections of spleens as previously described (Su et al., 1997).
trast, PU.11/2Spi-B2/2 mice show a decreased number
of peripheral B cells. A previous study has demonstrated Cell Purification and Proliferation
B cells were purified from mouse spleens as previously describedthe requirement for a positive signal through the BCR
(Su et al., 1997). B cell purity as assayed by flow cytometry withcomplex to allow maturation of B cells into the peripheral
a B220 mAb was approximately 95% for wild-type, Spi-B2/2, andpool (Torres et al., 1996). It may be that, in addition to
PU.11/2Spi-B1/2 animals and 85% for PU.11/2Spi-B2/2 (the contami-
the increased apoptosis observed in PU.11/2Spi-B2/2 B nating cells were largely TER1191 erythroid precursors). In vitro
cells, mutant cells also fail to mature properly due to proliferation assays were performed as previously described (Su et
al., 1997). Anti-IgM antibody (50 or 3 mg/ml, affinity pure F(ab9)2lack of a positive selection.
fragment, goat anti-mouse IgM, m chain specific; Jackson Immu-
noResearch Laboratories), LPS (50 mg/ml), PMA (10 ng/ml) plusNormal B Lymphopoiesis in Mutant Mice
ionomycin (0.5 mg/ml), anti-CD40 antibody (10 mg/ml, purified ratGiven the extremely inefficient tyrosine phosphorylation
anti-mouse CD40; Pharmingen), and IL-4 (10 ng/ml, recombinant
evident in Figure 5A, it is surprising that PU.11/2Spi-B2/2 mouse IL-4; Pharmingen) were given as soluble stimulants. Cells
B cells undergo lymphopoiesis apparently normally. were pulsed with [3H]-thymidine at 1 mCi/ml after 48 hr and counted
16 hr after thymidine treatment.Proliferation and differentiation of B lineage precursors
Normal BCR Signaling Requires PU.1 and Spi-B
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Cell Stimulation, Western Blotting, and Immunoprecipitations Campbell, M.A., and Klinman, N.R. (1995). Phosphotyrosine-depen-
dent association between CD22 and protein tyrosine phosphataseB cells purified from mouse spleens were resuspended at 4 3 107
1C. Eur. J. Immunol. 25, 1573±1579.cells/ml in 13 Dulbecco's phosphate-buffered saline (PBS) (GIBCO-
BRL) and incubated at 378C for 10 min prior to stimulation. Cells Chen, J., Trounstine, M., Kurahara, C., Young, F., Kuo, C.C., Xu, Y.,
were then stimulated for 1 min with either media alone, anti-IgM Loring, J.F., Alt, F.W., and Huszar, D. (1993). B cell development in
antibody (50 mg/ml, affinity purified F(ab')2 fragment, goat anti- mice that lack one or both immunoglobulin kappa light chain genes.
mouse IgM [m chain specific] Jackson ImmunoResearch Labora- EMBO J. 12, 821±830.
tories), or a sodium pervanadate solution (0.3% H2O2 and 2.5 mM Chen, H., Ray-Gallet, D., Zhang, P., Hetherington, C.J., Gonzalez,
Na3VO4). Cells were lysed by adding an equal volume of 23 NETN D.A., Zhang, D.E., Moreau-Gachelin, F., and Tenen, D.G. (1995a).
Buffer (40 mM Tris HCl [pH 8.0], 275 mM NaCl, 40% glycerol, 2% PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene
NP-40, 4 mM EDTA [pH 8.0], 2 mM Na3VO4, 20 mM NaF, 2 mM 11, 1549±1560.
phenylmethylsulfonyl fluoride (PMSF), 20 mg/ml aprotinin, and 20 Chen, H.-M., Zhang, P., Voso, M., Hohaus, S., Gonzalez, D., Glass,
mg/ml leupeptin) and then incubated on ice for 20 min and centri- C., Zhang, D.-E., and Tenen, D. (1995b). Neutrophils and monocytes
fuged to remove cellular debris. express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85, 2918±
For immunoprecipitations, lysates of 5 3 106 cells prepared as 2928.
described above were incubated with antibody (3 mg rabbit anti-
Cheng, A.M., Rowley, B., Pao, W., Hayday, A., Bolen, J.B., andIga antiserum purified by Protein A chromatography, 2 mg anti-
Pawson, T. (1995). Syk tyrosine kinase required for mouse viability
PLCg2 [Santa Cruz Biotechnology], or 5 ml of anti-BLNK antiserum
and B-cell development. Nature 378, 303±306.
[a kind gift of Dr. Andrew Chan]) followed by the addition of Protein
Cooke, M.P., Heath, A.W., Shokat, K.M., Zeng, Y., Finkelman, F.D.,A sepharose (Sigma). Immunoprecipitates were collected by centri-
Linsley, P.S., Howard, M., and Goodnow, C.C. (1994). Immunoglobu-fugation and washed three times with ice-cold 13 NETN buffer.
lin signal transduction guides the specificity of B cell-T cell interac-After a final wash, beads were resuspended in 23 SDS PAGE gel
tions and is blocked in tolerant self-reactive B cells. J. Exp. Med.loading buffer and boiled.
179, 425±438.Samples were boiled and applied to 8%±10% SDS polyacrylamide
Couture, C., Williams, S., Gauthier, N., Tailor, P., and Mustelin, T.gels for electrophoresis. Proteins were transferred to nitrocellulose
(1997). Role of Tyr518 and Tyr519 in the regulation of catalytic activ-as described (Sambrook et al., 1989) and membranes were blocked
ity and substrate phosphorylation by Syk protein-tyrosine kinase.in 5% nonfat dry milk in TBST (10 mM Tris HCl [pH 7.5], 150 mM
Eur. J. Biochem. 246, 447±451.NaCl, and 0.1% Tween-20) or in 3% bovine serum albumin (BSA) in
Eisenbeis, C.F., Singh, H., and Storb, U. (1993). PU.1 is a componentTBST. Primary antibodies (4G10 anti-phosphotyrosine monoclonal
of a multiprotein complex which binds an essential site in the murine[Upstate Biotechnology], anti-Iga polyclonal, anti-PLCg2 polyclonal,
immunoglobulin lambda 2±4 enhancer. Mol. Cell. Biol. 13, 6452±and anti-BLNK polyclonal [described above], or anti-syk polyclonal
6461.[a kind gift of Dr. J. Cambier]) were diluted to appropriate concentra-
tions and incubated with the membranes overnight at 48C. Horserad- Feldhaus, A.L., Mbangkollo, D., Arvin, K.L., Klug, C.A., and Singh,
ish peroxidase-labeled goat anti-rabbit or goat anti-mouse second- H. (1992). BLyF, a novel cell-type- and stage-specific regulator of
ary antibody (GIBCO-BRL) was incubated at 1:5000 dilution in 5% the B-lymphocyte gene mb-1. Mol. Cell. Biol. 12, 1126±1133.
milk/TBST or 3% BSA/TBST. The membranes were then washed Fu, C., Turck, C.W., Kurosaki, T., and Chan, A.C. (1998). BLNK: a
and developed with a LumiGLO Chemiluminescent Detection Kit central linker protein in B cell activation. Immunity 9, 93±103.
(Kirkegaard and Perry Laboratories [KPL]) to visualize the signal. Gold, M.R., Matsuuchi, L., Kelly, R.B., and DeFranco, A.L. (1991).
Tyrosine phosphorylation of components of the B-cell antigen re-
Measurement of Intracellular Calcium Concentration ceptors following receptor crosslinking. Proc. Natl. Acad. Sci. USA
Intracellular calcium elevation was measured as described by Novak 88, 3436±3440.
and Rabinovitch (1994). In brief, purified B cells (107 cells/ml) were Gong, S., and Nussenzweig, M.C. (1996). Regulation of an early
incubated at 378C for 45 min with Fluo-3 (Molecular Probes) and developmental checkpoint in the B cell pathway by Ig beta. Science
Fura-Red (Molecular Probes) in RPMI-1640 supplemented with 5% 272, 411±414.
FBS. Cells were washed and held on ice until stimulation. Immedi- Hagman, J., and Grosschedl, R. (1992). An inhibitory carboxyl-termi-
ately prior to stimulation, cells were warmed to 378C for 2 min, nal domain in Ets-1 and Ets-2 mediates differential binding of ETS
and basal Ca21 concentration was measured for 30 s. Stimulation family factors to promoter sequences of the mb-1 gene. Proc. Natl.
through the BCR was achieved with aIgM (Jackson Immunore- Acad. Sci. USA 89, 8889±8893.
search) at 50 mg/ml. The changes in fluorescence were determined
Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D., and Haya-for an additional 4 min after aIgM treatment.
kawa, K. (1991). Resolution and characterization of Pro-B and Pre-
Pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173,
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